spacer
home > pmps > summer 2017 > see attached
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

See Attached

PMPS: What are the most innovative and effective delivery systems currently available in parenteral technologies and why?

Dr Mike Schaefers: In the current market, combination products are becoming more popular, and one of the most innovative types is wearable drug delivery systems. For most patients with chronic conditions who must regularly self-inject doses of medication, an easy-to-use, integrated delivery and administration system such as a wearable injector can be key to creating the reliability that allows for compliance with treatment plans.

For example, a single-use, electronic wearable injector that adheres to the patientís body is discreet, intuitive and designed to minimise discomfort. These can be pre-programmed to deliver high volumes of viscous or sensitive products over time, making self-administration of medication easier for the patient outside of the clinical setting.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Mike Schaefers, Vice President (VP) of Global Product Management and Marketing Operations at West Pharmaceutical Services, Inc., is responsible for building and executing the enterprise-wide product portfolio strategy. He previously served as VP in Global Marketing for the companyís Packaging System Division. He joined West in 2000 as Director of the Technical Customer Service Group for the European and Asia- Pacific markets, before becoming VP of Marketing in Europe, responsible for the regionís marketing and technical support. Dr Schaefers earned his PhD in chemistry from Ruhr University in Bochum, Germany, and a diploma in business management from IHK in Essen, Germany.
spacer
Dr Mike Schaefers
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Positive results from first preclinical in-vivo studies of Affimer therapeutics


More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

BioProcess International Conference & Exhibition (BPI)

25-28 September 2017, Hynes Convention Center, Boston, Massachusetts, USA

BioProcess International Conference & Exhibition (BPI) is the largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement